Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Balsalazide Disodium Capsules USP, 750 mg.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg and 40 mg.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture and market Ephedrine Sulfate Injection USP, 50 mg/mL single-dose vials.
Zydus Lifesciences Ltd has received final approval from the United States Food and Drug Administration to manufacture and market Sucralfate Tablets USP, 1 gram.